Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Minoxidil response testing helps treat hair loss effectively and safely.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Artificial hair fibers improve drug delivery accuracy through skin models.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Fast-dissolving nifedipine tablets were successfully developed for better oral delivery.

A 3D model of Dupuytren’s disease was developed for better drug testing.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

An arthritis drug helped a person with severe hair loss regrow their hair.

Finasteride's link to depression is questionable due to study flaws and potential bias.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Nanocarriers can improve skin treatments by effectively delivering drugs and enhancing skin hydration.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

A woman with severe angioedema improved significantly after treatment with rituximab.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.